KT5720
![]() | |
| Names | |
|---|---|
| IUPAC name
(5R,6S,8S)-Hexyl 6-hydroxy-5-methyl-13-oxo-6,7,8,13,14,15-hexahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacene-6-carboxylate | |
| Other names
KT 5720 | |
| Identifiers | |
| 108068-98-0 | |
| 3D model (Jmol) | Interactive image |
| ChEBI | CHEBI:85085 |
| ChemSpider | 399960 |
| ECHA InfoCard | 100.238.838 |
| PubChem | 454202 |
| UNII | 58HV29I28S |
| |
| |
| Properties | |
| C32H31N3O5 | |
| Molar mass | 537.62 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
KT5720 is a kinase inhibitor with specificity towards protein kinase A.[1] It is a semi-synthetic derivative of K252a[2] and analog of staurosporine.
References
- ↑ Makarevich, A. V.; Sirotkin, A. V.; Rafay, J. (2010). "Comparison of Effects of Protein Kinase A, Mitogen-activated Protein Kinase, and Cyclin-dependent Kinase Blockers on Rabbit Ovarian Granulosa Cell Functions". Hormone and Metabolic Research. 42 (13): 936–43. doi:10.1055/s-0030-1267226. PMID 20972940.
- ↑ CID 3844 from PubChem
This article is issued from Wikipedia - version of the 10/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
